UK regulators approve injectable form of nivolumab for solid tumours
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
The Medicines and Healthcare products Regulatory Agency (MHRA) in the [...]
There are several types of kidney cancer, the most common [...]
The Committee for Medicinal Products for Human Use (CHMP) of [...]
People with kidney cancer have been shown to have changes (mutations) in [...]
The KEYMAKER-U03 study is looking at different combinations of immunotherapy [...]
The Food and Drug Administration (FDA) in America has accepted [...]
A new personalised cancer vaccine has shown promising anti-tumour immunity [...]
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for [...]
Updated results from the phase 2 LITESPARK-003 trial with belzutifan [...]
Combinations of tyrosine kinase inhibitors plus immunotherapy have improved treatment [...]